When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress

Abstract Background Oral artemisinin monotherapy (AMT), an important contributor to multi-drug resistant malaria, has been banned in Nigeria. While oral AMT has scarcely been found for several years now in other malaria-endemic countries, availability has persisted in Nigeria’s private sector. In 20...

Full description

Bibliographic Details
Main Authors: ACTwatch Group, Chinazo Ujuju, Jennifer Anyanti, Paul N. Newton, Godwin Ntadom
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Malaria Journal
Subjects:
Oral artemisinin monotherapy
Market share
Manufacturing
Anti-malarial products
Availability
Drug-resistance
Online Access:http://link.springer.com/article/10.1186/s12936-017-2102-7

Internet

http://link.springer.com/article/10.1186/s12936-017-2102-7

Similar Items